BTIG raised the firm’s price target on Upwork (UPWK) to $18 from $16 and keeps a Buy rating on the shares as part of a broader research note ...

As of the latest trading close, AKBA, a Healthcare sector stock, is trading -14.11% below its 52-week high but remains 166.25% above its 52-week low. The Average True Range (ATR) (14 days) of 0.1 ...

FiscalNote Holdings Inc (NOTE) stock saw a modest uptick, ending the day at $1.05 which represents a slight increase of $0.18 or 20.69% from the prior close of $0.87. The stock opened at $1 and ...

Fintel reports that on December 2, 2024, BTIG initiated coverage of BrightView Holdings (NYSE:BV) with a Buy recommendation.

BTIG downgraded AnaptysBio (ANAB) to Neutral from Buy without a price target The company’s topline data from the Phase 2b trial of ANB032 in ...

Fintel reports that on December 2, 2024, BTIG downgraded their outlook for AnaptysBio (NasdaqGS:ANAB) from Buy to Neutral.

Outlook Therapeutics (NASDAQ:OTLK – Free Report) had its target price reduced by BTIG Research from $50.00 to $9.00 in a ...

Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...

BTIG analyst Andrew Harte is praising MicroStrategy's (NASDAQ:MSTR) plan announced at the end of October to raise $42B of ...

BTIG lowered the firm’s price target on Outlook Therapeutics (OTLK) to $9 from $50 and keeps a Buy rating on the shares. The ...

Investing.com -- According to a note from BTIG on Monday, the tech sector's ongoing weakness is raising concerns as markets ...

Jacob, Ph.D., will be participating in one on one meetings and a fireside chat at the 4 th Annual Virtual BTIG Ophthalmology ...